667, L.P., Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 113,459 shares at $80.07 ($9.0M) on 2018-11-13, disclosed to the SEC on 2018-11-13.
Open-market sale of $9.0M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.13 | 657 | $52K | 0.6% |
| 2 | $79.13 | 5,885 | $466K | 5.2% |
| 3 | $79.13 | 1,014 | $80K | 0.9% |
| 4 | $79.13 | 38,330 | $3.0M | 33.5% |
| 5 | $80.07 | 8,139 | $652K | 7.2% |
| 6 | $80.07 | 53,013 |
| $4.2M |
| 46.9% |
| 7 | $80.07 | 814 | $65K | 0.7% |
| 8 | $80.07 | 908 | $73K | 0.8% |
| 9 | $80.07 | 1,403 | $112K | 1.2% |
| 10 | $80.09 | 3,296 | $264K | 2.9% |
| Total | $79.69 avg | 113,459 | $9.0M | 100% |
| Filing → |
| MDGL | BUY | 2023-12-14 | $14.7M | — | Filing → |
| ACAD | BUY | 2023-05-24 | $45.4M | — | Filing → |
| TCRX | BUY | 2022-05-12 | $4.8M | — | Filing → |